Literature DB >> 20702688

SV2 regulates neurotransmitter release via multiple mechanisms.

Amy Nowack1, Jia Yao, Kenneth L Custer, Sandra M Bajjalieh.   

Abstract

Among the proteins that mediate calcium-stimulated transmitter release, the synaptic vesicle protein 2 (SV2) stands out as a unique modulator specific to the neurons and endocrine cells of vertebrates. In synapses, SV2 regulates the expression and trafficking of the calcium sensor protein synaptotagmin, an action consistent with the reduced calcium-mediated exocytosis observed in neurons lacking SV2. Yet SV2 contains amino acid motifs consistent with it performing other actions that could regulate presynaptic functioning and that might underlie the mechanism of drug action. To test the role of these functional motifs, we performed a mutagenic analysis of SV2A and assessed the ability of mutant SV2A proteins to restore normal synaptic transmission in neurons from SV2A/B knockout mice. We report that SV2A-R231Q, harboring a mutation in a canonical transporter motif, restored normal synaptic depression (a measure of release probability and signature deficit of neurons lacking SV2). In contrast, normal synaptic depression was not restored by SV2A-W300A and SV2A-W666A, harboring mutations of conserved tryptophans in the 5th and 10th transmembrane domains. Although they did not rescue normal neurotransmission, SV2A-W300A and SV2A-W666A did restore normal levels of synaptotagmin expression and internalization. This indicates that tryptophans 300 and 666 support an essential action of SV2 that is unrelated to its role in synaptotagmin expression or trafficking. These results indicate that SV2 performs at least two actions at the synapse that contribute to neurotransmitter release.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20702688      PMCID: PMC2980308          DOI: 10.1152/ajpcell.00259.2010

Source DB:  PubMed          Journal:  Am J Physiol Cell Physiol        ISSN: 0363-6143            Impact factor:   4.249


  48 in total

1.  Chemical chaperones correct the mutant phenotype of the delta F508 cystic fibrosis transmembrane conductance regulator protein.

Authors:  C R Brown; L Q Hong-Brown; J Biwersi; A S Verkman; W J Welch
Journal:  Cell Stress Chaperones       Date:  1996-06       Impact factor: 3.667

2.  SV2B regulates synaptotagmin 1 by direct interaction.

Authors:  Diana R Lazzell; Roger Belizaire; Pratima Thakur; David M Sherry; Roger Janz
Journal:  J Biol Chem       Date:  2004-10-05       Impact factor: 5.157

3.  Synaptic vesicle protein 2 enhances release probability at quiescent synapses.

Authors:  Kenneth L Custer; Naola S Austin; Jane M Sullivan; Sandra M Bajjalieh
Journal:  J Neurosci       Date:  2006-01-25       Impact factor: 6.167

4.  Levetiracetam as an adjunctive analgesic in neoplastic plexopathies: case series and commentary.

Authors:  Edwin D Dunteman
Journal:  J Pain Palliat Care Pharmacother       Date:  2005

5.  SV2A and SV2C are not vesicular Ca2+ transporters but control glucose-evoked granule recruitment.

Authors:  Mariella Iezzi; Sten Theander; Roger Janz; Chantal Loze; Claes B Wollheim
Journal:  J Cell Sci       Date:  2005-12-01       Impact factor: 5.285

6.  SV2A and SV2C contain a unique synaptotagmin-binding site.

Authors:  Amanda E Schivell; Sumiko Mochida; Patricia Kensel-Hammes; Kenneth L Custer; Sandra M Bajjalieh
Journal:  Mol Cell Neurosci       Date:  2005-05       Impact factor: 4.314

7.  The effect of levetiracetam on essential tremor.

Authors:  Khalafalla O Bushara; Taimur Malik; Rupert E Exconde
Journal:  Neurology       Date:  2005-03-22       Impact factor: 9.910

8.  Levetiracetam in social phobia: a placebo controlled pilot study.

Authors:  Wei Zhang; Kathryn M Connor; Jonathan R T Davidson
Journal:  J Psychopharmacol       Date:  2005-09       Impact factor: 4.153

9.  Specific effect of levetiracetam in experimental human pain models.

Authors:  Thomas P Enggaard; Niels A Klitgaard; Søren H Sindrup
Journal:  Eur J Pain       Date:  2005-06-08       Impact factor: 3.931

10.  Tryptophan 388 in putative transmembrane segment 10 of the rat glucose transporter Glut1 is essential for glucose transport.

Authors:  T Kasahara; M Kasahara
Journal:  J Biol Chem       Date:  1998-10-30       Impact factor: 5.157

View more
  45 in total

1.  Electroporation of the hindbrain to trace axonal trajectories and synaptic targets in the chick embryo.

Authors:  Ayelet Kohl; Yoav Hadas; Avihu Klar; Dalit Sela-Donenfeld
Journal:  J Vis Exp       Date:  2013-05-29       Impact factor: 1.355

2.  Control of axon guidance and neurotransmitter phenotype of dB1 hindbrain interneurons by Lim-HD code.

Authors:  Ayelet Kohl; Till Marquardt; Avihu Klar; Dalit Sela-Donenfeld
Journal:  J Neurosci       Date:  2015-02-11       Impact factor: 6.167

3.  Changes in the Gene Expression Profiles of the Inferior Colliculus Following Unilateral Cochlear Ablation in Adult Rats.

Authors:  Hog Kwon Kil; Kyung Woon Kim; Da-Hye Lee; So Min Lee; Chang Ho Lee; So Young Kim
Journal:  Biochem Genet       Date:  2021-01-30       Impact factor: 1.890

4.  Kindling-induced asymmetric accumulation of hippocampal 7S SNARE complexes correlates with enhanced glutamate release.

Authors:  Elena A Matveeva; Verda A Davis; Sidney W Whiteheart; Thomas C Vanaman; Greg A Gerhardt; John T Slevin
Journal:  Epilepsia       Date:  2011-12-09       Impact factor: 5.864

Review 5.  Synaptic vesicle protein 2: A multi-faceted regulator of secretion.

Authors:  Kristine Ciruelas; Daniele Marcotulli; Sandra M Bajjalieh
Journal:  Semin Cell Dev Biol       Date:  2019-03-21       Impact factor: 7.727

6.  Biodistribution and Radiation Dosimetry for the Novel SV2A Radiotracer [(18)F]UCB-H: First-in-Human Study.

Authors:  F Bretin; M A Bahri; C Bernard; G Warnock; J Aerts; N Mestdagh; T Buchanan; C Otoul; F Koestler; F Mievis; F Giacomelli; C Degueldre; R Hustinx; A Luxen; A Seret; A Plenevaux; E Salmon
Journal:  Mol Imaging Biol       Date:  2015-08       Impact factor: 3.488

7.  Kinetic evaluation and test-retest reproducibility of [11C]UCB-J, a novel radioligand for positron emission tomography imaging of synaptic vesicle glycoprotein 2A in humans.

Authors:  Sjoerd J Finnema; Nabeel B Nabulsi; Joël Mercier; Shu-Fei Lin; Ming-Kai Chen; David Matuskey; Jean-Dominique Gallezot; Shannan Henry; Jonas Hannestad; Yiyun Huang; Richard E Carson
Journal:  J Cereb Blood Flow Metab       Date:  2017-08-09       Impact factor: 6.200

8.  Modulation of the conformational state of the SV2A protein by an allosteric mechanism as evidenced by ligand binding assays.

Authors:  V Daniels; M Wood; K Leclercq; R M Kaminski; M Gillard
Journal:  Br J Pharmacol       Date:  2013-07       Impact factor: 8.739

9.  Levetiracetam has opposite effects on alcohol- and cocaine-related behaviors in C57BL/6J mice.

Authors:  J Elliott Robinson; Meng Chen; Alice M Stamatakis; Michael C Krouse; Elaina C Howard; Sara Faccidomo; Clyde W Hodge; Eric W Fish; C J Malanga
Journal:  Neuropsychopharmacology       Date:  2013-01-25       Impact factor: 7.853

10.  A presynaptic role for PKA in synaptic tagging and memory.

Authors:  Alan Jung Park; Robbert Havekes; Jennifer Hk Choi; Vince Luczak; Ting Nie; Ted Huang; Ted Abel
Journal:  Neurobiol Learn Mem       Date:  2014-05-29       Impact factor: 2.877

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.